MEDIZEN HUMANCARE Co., Ltd. engages in the development and provision of medical and pharmacological research, genomic analyzing, and disease forecasting services. Its services include gene information database establishment, genetic testing, medical researches, diagnosis kit development, and others. The company was founded on July 20, 2012 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company